AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 65 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $144,000 | +71.4% | 6,500 | 0.0% | 0.00% | – |
Q2 2021 | $84,000 | 0.0% | 6,500 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $84,000 | -6.7% | 6,500 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $90,000 | -6.2% | 6,500 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $96,000 | -9.4% | 6,500 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $106,000 | +12.8% | 6,500 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $94,000 | -28.8% | 6,500 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $132,000 | +277.1% | 6,500 | 0.0% | 0.00% | – |
Q3 2019 | $35,000 | -18.6% | 6,500 | 0.0% | 0.00% | – |
Q2 2019 | $43,000 | +2.4% | 6,500 | 0.0% | 0.00% | – |
Q1 2019 | $42,000 | -4.5% | 6,500 | 0.0% | 0.00% | – |
Q4 2018 | $44,000 | +2.3% | 6,500 | 0.0% | 0.00% | – |
Q3 2018 | $43,000 | +16.2% | 6,500 | 0.0% | 0.00% | – |
Q2 2018 | $37,000 | +8.8% | 6,500 | 0.0% | 0.00% | – |
Q1 2018 | $34,000 | +17.2% | 6,500 | 0.0% | 0.00% | – |
Q4 2017 | $29,000 | -29.3% | 6,500 | 0.0% | 0.00% | – |
Q3 2017 | $41,000 | +2.5% | 6,500 | 0.0% | 0.00% | – |
Q2 2017 | $40,000 | -16.7% | 6,500 | 0.0% | 0.00% | – |
Q1 2017 | $48,000 | – | 6,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |